Skip to main content
. 2016 Mar 15;18(7):919–927. doi: 10.1093/neuonc/now025

Table 1.

Patient characteristics and follow-up

ID Sex Age, y Topography Cystic Symptoms Type of Surgery RT/CT Mib1 NF Chromosome 19 Relapse Death PFS, y OS, y
1 F 9.6 Frontal 0 Seizure Complete RT 15 0 Normal Remission Alive 7.6 7.6
2 M 0.8 Fronto-parietal 0 Seizure Complete CT 40 5 Normal Remission Alive 7.8 7.8
3 M 11.7 Frontal 1 Seizure Complete RT + CT 20 0 Polysomy Remission Alive 15.9 15.9
4 M 21.2 Occipital 1 Headache Complete RT 15 0 Trisomy Remission Alive 5.1 5.1
5 M 7.0 Frontal ICH Complete None 10 0 Trisomy Progressive Dead 0.3 1.3
6 M 11.5 Occipital 1 Headache Complete None 30 0 Trisomy Progressive Dead 1.2 2.4
7 F 31.8 Temporal 1 Seizure and ICH Complete RT 25 0 Trisomy Progressive Dead 0.5 1.1
8 F 10.7 Frontal 1 Headache 40 0 Trisomy Progressive Alive 8.5 17.5
9 M 0.9 Parietal 1 Deficit Complete CT 25 15 Trisomy Remission Alive 9.0 9.0
10 M 6.5 Parieto-occipital 0 ICH Complete RT 10 0 Normal Remission Alive 10.6 10.6
11 M 19.1 Frontal 1 Deficit Complete RT 40 5 Trisomy Progressive Dead 1.7 3.8
12 F 10.1 Parietal 1 ICH Complete RT 30 5 Trisomy Remission Alive 7.0 7.0
13 M 36.8 Frontal 1 Headache Subtotal RT + CT 40 0 Normal Progressive Dead 11.5 11.5
14 M 12.7 Parieto-occipital 1 ICH Complete RT 25 0 Normal Progressive Dead 4.9 4.9
15 M 2.5 Fronto-Parieto-occipital 0 ICH Complete RT + CT 10 10 Trisomy Remission Alive 7.4 7.4
16 M 10.6 Parietal 0 Seizure Complete None 30 0 Polysomy Progressive Alive 11.8 16.2
17 F 68.4 Frontal 0 Headache Subtotal RT 20 0 Trisomy Progressive Alive 4.7 9.7
18 F 4.4 Frontal 1 Headache Complete None 15 0 Trisomy Progressive Alive 15.8 22.2
19 M 9.8 Frontal 0 Headache Complete RT 60 15 Trisomy and tetrasomy Remission Alive 0.5 0.5
20 M 9.4 Temporal 1 Seizure Complete RT 25 0 Trisomy and tetrasomy Remission Alive 0.8 0.8

Abreviations: ICH, intracranial hypertension; RT, radiotherapy; CT, chemotherapy; NF, neurofilament.

PFS and OS are in years. 1 = present; 0 = absent. Mib1 and NF expression rates are given in percentage of immunoreactive cells.